Overview
Sperax aims to build a more efficient and autonomous decentralized economy than traditional economic models. Sperax offers USDs, a stablecoin pegged to the value of the U.S. dollar. USDs is a hybrid stablecoin backed by crypto collateral and stabilized through algorithmic mechanisms that adjust to keep its value at $1. Among hybrid stablecoins, it was the first to introduce an automatic interest-yield feature. To mint USDs, users must provide a certain amount of SPA tokens along with crypto collateral such as USDT or USDC, and the SPA tokens used in the process are burned. SPA is the utility token of the Sperax network, used to mint and help maintain the peg of USDs, while also serving as a governance token.
Metric Radar Chart
Metric Bar Chart
Metric Trends
| Total Rating Score | TL2Gradual Downtrend |
|---|---|
| Market Accessibility | TNNeutral |
| Development Activity | TNNeutral |
| Market Liquidity | TNNeutral |
| Community Engagement | TL2Gradual Downtrend |
| Risk & Security | TL2Gradual Downtrend |
Total Rating Score Trend
Market Data
- Token Price $0.004315 (↗0.02%)
- Volume (24h) $1.45M (↘63.02%)
- Market Cap $8.84M (↘4.51%)
-
Circulating Supply
2,048,202,287 SPA
2,433,548,940 SPA
(Source : Coinmarketcap , Coingecko )
Community Info
X (Twitter) Tweets (Last 30 Days)
61 (+5)
Development Info
-
GitHub Account
Sperax
-
Stars
49 (-)
- Commits (Last 3 Months) 0 (-)
Security Audit Info
- Security Audit Status CertiK
- CertiK Code Security Score 86 pts
(Source : Coinmarketcap , CertiK Skynet )
Issue Info
- Trading History
- No records found
- Risk History
- No records found
View Full History
| Category | Date | Exchange | Link | Grade | Details |
|---|---|---|---|---|---|
| Regular Evaluation | 2025-05-26 | - | - | B-(59.24) | [AW-0059-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-22 | - | - | B-(59.99) | [AW-0058-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-19 | - | - | B-(58.43) | [AW-0057-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-15 | - | - | B-(58.94) | [AW-0056-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-12 | - | - | B-(58.70) | [AW-0055-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-08 | - | - | B-(57.29) | [AW-0054-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-05 | - | - | B-(56.93) | [AW-0053-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-05-01 | - | - | B-(58.70) | [AW-0052-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-28 | - | - | B-(57.41) | [AW-0051-정기] 평가가 완료되었습니다. |
| Regular Evaluation | 2025-04-24 | - | - | B-(58.97) | [AW-0050-정기] 평가가 완료되었습니다. |
- Disclaimer
-
The ratings provided by APYWA (hereinafter 'the Company') are conducted via an automated system based on public data and are pure data-driven analysis results with no subjective elements. This rating material includes evaluations on five key metrics: Market Accessibility, Development Activity, Market Liquidity, Community Engagement, and Security. All information provided is for reference purposes only.
Our ratings are not intended as investment advice or recommendations, and we do not guarantee the accuracy, completeness, or timeliness of the information. Users must make their own investment decisions based on the provided data, and the Company bears no legal liability for any resulting losses or damages.
While the rating material is processed automatically based on reliable data, discrepancies with actual market conditions may occur due to data limitations. Therefore, the Company is not liable for any damages arising from the use of the provided information. All information contained herein is the property of the Company and may not be reproduced, distributed, or modified without prior approval.

Sperax
SPA 













